$PH

Parker-Hannifin Corp (PH): Completion of Acquisition or Disposition of Assets

Parker-Hannifin Corp (PH) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. 8-K Parker-Hannifin Corp false 0000076334 0000076334 2026-08-13 2026-08-13 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event

Original reporting
Published Aug 13, 2026, 8:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 8:09 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefMergers & acquisitions
Primary signal
$PH
Neutral
medium confidence
Mentioned
$PH
Relevance
9/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$PHNeutralMed
01

Why it matters

The key new information is the closing date and the specific term-loan borrowings used to fund part of the purchase price and fees, which can influence leverage metrics and interest expense expectations.

02

Market read

Traders can update PH’s leverage and deal-execution certainty immediately based on the confirmed close and the $7.75B term-loan borrowings.

03

What to watch

The filing does not disclose post-close integration milestones, cost synergies, or any change to financing terms beyond the borrowed amounts, so near-term price may hinge on what the market already priced from the Nov. 2025 agreement.

Relevance 9/10Novelty 8/10Timing: after-hours/filing today, Aug. 13, 2026 completion confirmation

Background

Parker-Hannifin agreed in Nov. 2025 to acquire Filtration Group for $9.25B cash-free, debt-free, and this 8-K confirms the merger closed on Aug. 13, 2026.

Company-level read

Ticker impact

$PHNeutralMedium confidence
Context

Parker-Hannifin completed its $9.25B acquisition of Filtration Group on Aug. 13, 2026 and funded it with $7.75B of term loans.

Expected impact

Likely modest volatility around leverage and integration headlines; direction depends on market view of deal accretion versus financing cost.

Evidence & confidence

The filing confirms completion date and financing amounts, but provides no incremental valuation, synergies, or guidance changes beyond previously disclosed terms.

Market effects

Industrial components and filtration peers may see read-through on consolidation appetite and financing conditions for M&A.

Limited direct regional impact; primarily US industrial credit and industrial M&A sentiment.

Moderate, as the deal is large but not a cross-border headline in the provided text.

Counterpoint

Completion reduces deal-execution risk; any initial debt concern may fade as investors re-rate the certainty of closing and integration progress.

Key entities

  • Parker-Hannifin Corporation

    Subject issuer that completed the Filtration Group acquisition and borrowed under two term-loan facilities.

  • Filtration Group Corporation

    Acquired company in the merger transaction completed on Aug. 13, 2026.

  • Barclays Bank PLC

    Administrative agent for the $5.25B 364-day term loan facility used to fund the deal.

  • KeyBank National Association

    Administrative agent for the $2.50B three-year term loan facility used to fund the deal.

Related articles

$PHHighAI 8/10

Is Wall Street Bullish or Bearish on Parker-Hannifin Stock?

Parker-Hannifin (PH) reported Q4 2026 earnings with revenue of $5.8B, up 9.8% YoY, and adjusted EPS of $8.54, exceeding estimates. The stock has risen 36.8% over the past year, outperforming the S&P 500 and its industry benchmark. Analysts maintain a 'Strong Buy' consensus, with a mean price target of $1,175.38, suggesting a 17.5% upside.

$PHMed

Parker-Hannifin (PH) Q4 2026 Earnings Call Transcript

Parker-Hannifin (PH) reported fiscal 2026 record sales of $21.5B, up 6.6% organically, and adjusted EPS of $32.31, up 18%. Q4 sales rose to $5.8B and adjusted EPS to $9.27. Management set FY2027 guidance for 5.5% to 8.5% organic growth and $34.25 to $35.25 EPS, plus a 30% margin target by FY2031 and a $12.8B backlog.

$PHMed

The Top 5 Analyst Questions From Parker

Parker-Hannifin reported Q2 revenue of $5.76B vs $5.57B estimates and adjusted EPS of $9.27 vs $8.27, citing strong organic growth, aerospace momentum, and demand in electronics and in-plant markets. CEO Jennifer Parmentier said Filtration Group and CIRCOR acquisitions should close in H2, with integration plans ready. 2027 adjusted EPS guidance midpoint is $34.75.

$PHHighAI 8/10

Parker-Hannifin Q4 Earnings Call Highlights

Parker-Hannifin (NYSE:PH) reported Q4 orders up 19% versus the prior three-month period and 12% on a rolling 12-month basis, with backlog up 16% to a record $12.8B. North American industrial sales were $2.2B, aerospace sales $1.9B, and aerospace backlog $8.5B. The company set a new 30% adjusted segment operating margin target by fiscal 2031 and initiated FY2027 sales growth guidance of 5.5% to 8.5%.